This is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences. This stock is trading up 12.1% at $21.13 in recent trading.Today's Volume: 4,494,000 Average Volume: 444,997 Volume % Change: 1073% Shares of AUXL are skyrocketing today after the company said Xiaflex, its treatment for Dupuytren's contracture (which causes curvature of the fingers due to tendon thickening and shortening), also proved effective in reducing curvature of the penis. From a technical perspective, AUXL is gapping up big here on monster volume. This move is quickly pushing the stock within range of triggering a major breakout trade. That trade will hit once AUXL takes out some near-term overhead resistance at $21.25 with high-volume. At last check, AUXL has hit an intraday high of $21.20 on volume that's well above its three-month average action. Traders should now look for long-biased trades in AUXL once it sustains a move or close over $21.25 with volume that's near or above 444,997. If we get that move today or soon, look for AUXL to continue its uptrend toward $25 in the near future.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts